Several lines of evidence suggest that GPR37 modulates dopamine signaling, both in PD and in other dopamine-linked disorders, such as bipolar disorder and major depressive disorder (Tomita et al., 2013). This evidence concerns the gene GPR37 and Parkinson disease.